Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatocellular carcinoma: a multidisciplinary approach].

Adrien A Tempia-Caliera1, Riadh Ksontini, Darius Moradpour

  • 1Service de chirurgie viscérale, CHUV, 1011 Lausanne. adrien.tempia@hospvd.ch

Revue Medicale Suisse
|July 21, 2005
PubMed
Summary

Hepatocellular carcinoma (HCC) treatment is complex. Liver transplantation offers the best survival for eligible patients, while surgery or ablation provides curative options for others, with 5-year survival reaching 50%.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secondary <i>BRAF</i>-mutated histiocytic/dendritic cell sarcoma transdifferentiated from follicular lymphoma with prolonged response to BRAF/MEK inhibition and subsequent evolution to high-grade B-cell lymphoma.

Journal of clinical pathology·2026
Same author

Impact of aetiology and liver stiffness on thrombin generation in compensated cirrhosis.

Thrombosis research·2026
Same author

International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment.

The Lancet. Oncology·2026
Same author

International multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards.

The Lancet. Oncology·2026
Same author

Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation: A Swiss Transplant Cohort Study analysis.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

[GLP-1 agonists : indications and pancreatic and endoscopic safety considerations].

Revue medicale suisse·2026

Area of Science:

  • Hepatobiliary diseases
  • Surgical oncology
  • Transplant surgery

Context:

  • Hepatocellular carcinoma (HCC) management requires a multidisciplinary approach.
  • Liver transplantation is the optimal treatment for select patients with cirrhosis and HCC.
  • Transplantation indications are restricted, necessitating alternative curative strategies for many patients.

Purpose:

  • To outline the current multidisciplinary treatment strategies for hepatocellular carcinoma (HCC).
  • To discuss the role of liver transplantation, surgical excision, and percutaneous ablative treatments in HCC management.
  • To emphasize the importance of patient selection, clinical status, hepatic function, and cancer stage in treatment decisions.

Summary:

  • Liver transplantation offers the best survival outcomes for eligible HCC patients.

Related Experiment Videos

  • For non-transplant candidates, surgical resection and percutaneous ablation can achieve curative results with a 5-year survival rate of 50%.
  • Treatment choice depends on clinical condition, liver function, and cancer stage; follow-up is essential for managing recurrences.

    • Impact:

    • Provides a framework for selecting appropriate HCC treatments based on individual patient factors.
    • Highlights the curability of HCC through various modalities, improving patient prognosis.
    • Underscores the need for continued surveillance and re-treatment algorithms for recurrent HCC.